Dean yLi's Net Worth
$44.3 Million
Who is Dean yLi?
Dean yLi has an estimated net worth of $44.3 Million. This is based on reported shares across multiple companies, which include Merck & Co., Inc., and RECURSION PHARMACEUTICALS, INC..
SEC CIK
Dean yLi's CIK is 0001837016
Past Insider Trading and Trends
2021 was Dean yLi's most active year for acquiring shares with 16 total transactions. Dean yLi's most active month to acquire stocks was the month of March. 2021 was Dean yLi's most active year for disposing of shares, totalling 20 transactions. Dean yLi's most active month to dispose stocks was the month of April. 2023 saw Dean yLi paying a total of $482,486.14 for 126,193 shares, this is the most they've acquired in one year. In 2021 Dean yLi cashed out on 3,959,022 shares for a total of $1,159,157.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merck & Co., Inc. (MRK) Snapshot price: $127.56
Executive VP & President, MRL
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
$93.79 | -$932,530.22 | 46.24K |
Feb 9
| |||
Form 4
| +125.77% | 25.76K |
$119.43 | $3,076,516.80 | 46.24K |
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
| +2.70% | 538 |
$115.47 | $62,122.86 | 20.47K |
May 1
| |||
Form 4
| +19.66% | 3.27K |
$109.88 | $359,857.00 | 19.93K |
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +2.44% | 392 |
$87.65 | $34,358.80 | 16.46K |
May 3
| |||
Form 4
| +3.46% | 538 |
$88.69 | $47,715.22 | 16.07K |
May 1
| |||
Form 4
| +24.30% | 3.02K |
$73.51 | $222,220.73 | 15.46K |
Feb 24
| |||
Form 4
| +3.85% | 456 |
$75.98 | $34,646.88 | 12.31K |
May 4
| |||
Form 4
| +10.94% | 1.17K |
$74.50 | $87,090.50 | 11.85K |
May 1 - May 3
| |||
Form 4
| +48.60% | 3.48K |
$72.62 | $253,080.70 | 10.66K |
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RECURSION PHARMACEUTICALS, INC. (RXRX) Snapshot price: $9.175
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.21% | 1.59K |
—
|
—
| 73.78K |
Jul 1
| |||
Form 4
| +22.16% | 13.1K |
—
|
—
| 72.19K |
Jun 3
| |||
Form 4
| +2.19% | 1.27K |
—
|
—
| 59.09K |
Apr 1
| |||
Form 4
| -6.44% | -29.00K |
$13.66 | -$396,213.83 | 421K |
Scheduled
|
Jan 9
| ||
Form 4
| +0.09% | 1.2K |
—
|
—
| 1.33M |
Jan 2
| |||
Form 4
| -32.06% | -626.05K |
—
|
—
| 1.33M |
Apr 21 - Oct 2
| |||
Form 4
| +0.25% | 1.61K |
—
|
—
| 637.46K |
Jul 3
| |||
Form 4
| +2.02% | 12.61K |
—
|
—
| 636.02K |
Jun 16
| |||
Form 4
| +0.28% | 1.72K |
—
|
—
| 623.41K |
Apr 3
| |||
Form 4
| +0.25% | 1.57K |
—
|
—
| 621.68K |
Jan 3
| |||
Form 4
| +0.18% | 1.09K |
—
|
—
| 620.11K |
Oct 3
| |||
Form 4
| +0.23% | 1.41K |
—
|
—
| 619.02K |
Jul 1
| |||
Form 4
| +3.03% | 18.14K |
—
|
—
| 617.61K |
Jun 14
| |||
Form 4
| +0.26% | 1.54K |
—
|
—
| 599.47K |
Apr 1
| |||
Form 4
| +0.11% | 659 |
—
|
—
| 597.92K |
Jan 3
| |||
Form 4
| -1.19% | -15.90K |
$20.48 | -$325,630.39 | 1.31M |
Scheduled
|
Dec 7
| ||
Form 4/A
| -1.41% | -19.10K |
$20.16 | -$384,962.04 | 1.33M |
Scheduled
|
Nov 17 - Nov 19
| ||
Form 4
| -3.20% | -19.10K |
$20.16 | -$384,962.04 | 578.16K |
Scheduled
|
Nov 17 - Nov 19
| ||
Form 4
| +0.09% | 543 |
—
|
—
| 597.26K |
Oct 1
| |||
Form 4
| +0.06% | 330 |
—
|
—
| 596.72K |
Jul 1
| |||
Form 4
| +1.47% | 55.38K |
—
|
—
| 3.82M |
Apr 20
| |||
Form 4
| +2.38% | 13.89K |
—
|
—
| 596.39K |
Apr 15 - Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||